NF2 and cancer: Furthermore, in two recent studies screening germline cancer susceptibility mutations in large cohort of MPM patients, NF2, was not identified as a cancer susceptibility gene (Panou et al., 2018; Pastorino et al., 2018), suggesting that NF2 mutations observed in our series in unexposed patient are likely somatic.